JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Dairy Science Vol. 85 No. 10 2512-2520
© 2002 by American Dairy Science Association ®
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, E. A.
Right arrow Articles by Hillerton, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berry, E. A.
Right arrow Articles by Hillerton, J. E.

The Effect of an Intramammary Teat Seal on New Intramammary Infections

E. A. Berry and J. E. Hillerton

Institute for Animal Health, Compton, Berkshire RG20 7NN, United Kingdom

Corresponding Author:
Elizabeth A. Berry; e-mail:
elizabeth.berry{at}bbsrc.ac.uk.

As concern over the possible overuse of antibacterials increases, attention has focused on reduction of antibiotic usage and on nonantibiotic alternatives. A nonantibiotic intramammary teat sealant, Teat Seal (Cross Vetpharm Group Ltd., Tallaght, Dublin, Ireland), has been available in Ireland, in combination with an intramammary tube of cloxacillin. Teat Seal has been reformulated for use in cows with low cell counts as an alternative to antibiotic dry cow therapy at the end of lactation. The product is now marketed as Orbeseal (Pfizer Animal Health). A comparison between this teat sealant and no treatment was made on new intramammary infections and clinical mastitis, on all cows within four herds, and on low cell count cows in three herds.

No cases of clinical mastitis in the dry period were observed in cows treated with Teat Seal (n = 197), whereas a significant number (6 cows) were observed in the untreated cows (n = 204). In all herds, significantly more new infections at calving were found in the untreated group (62 cows in the untreated group compared with 21 cows in the Teat Seal group). In those quarters where infections were first detected at calving, the incidence of clinical mastitis was significantly greater in the untreated group. Quarters in both treatment groups that were infected at drying off with Corynebacterium spp. or coagulase-negative staphylococci were not protected against new infections and had an increased risk of new infection by Streptococcus uberis. The results will inform those restricting their use of antibiotic dry cow therapy in alternative management strategies and the additional risk of new intramammary infection.

Key Words: Orbeseal • Teat Seal • intramammary infection • mastitis)

Abbreviation key: CNS = coagulase-negative staphylococci




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
K. I. Parker, C. W. R. Compton, F. M. Anniss, C. Heuer, and S. McDougall
Quarter-Level Analysis of Subclinical and Clinical Mastitis in Primiparous Heifers Following the Use of a Teat Sealant or an Injectable Antibiotic, or Both, Precalving
J Dairy Sci, January 1, 2008; 91(1): 169 - 181.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. J. Green, A. J. Bradley, G. F. Medley, and W. J. Browne
Cow, Farm, and Management Factors During the Dry Period that Determine the Rate of Clinical Mastitis After Calving
J Dairy Sci, August 1, 2007; 90(8): 3764 - 3776.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
K. Huijps and H. Hogeveen
Stochastic Modeling to Determine the Economic Effects of Blanket, Selective, and No Dry Cow Therapy
J Dairy Sci, March 1, 2007; 90(3): 1225 - 1234.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
E. A. Berry and J. E. Hillerton
Effect of an Intramammary Teat Seal and Dry Cow Antibiotic in Relation to Dry Period Length on Postpartum Mastitis
J Dairy Sci, February 1, 2007; 90(2): 760 - 765.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
K. I. Parker, C. Compton, F. M. Anniss, A. Weir, C. Heuer, and S. McDougall
Subclinical and Clinical Mastitis in Heifers Following the Use of a Teat Sealant Precalving
J Dairy Sci, January 1, 2007; 90(1): 207 - 218.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
S. Godden, P. Rapnicki, S. Stewart, J. Fetrow, A. Johnson, R. Bey, and R. Farnsworth
Effectiveness of an Internal Teat Seal in the Prevention of New Intramammary Infections During the Dry and Early-Lactation Periods in Dairy Cows when used with a Dry Cow Intramammary Antibiotic
J Dairy Sci, December 1, 2003; 86(12): 3899 - 3911.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
E. A. Berry, W. T. Johnston, and J. E. Hillerton
Prophylactic Effects of Two Selective Dry Cow Strategies Accounting for Interdependence of Quarter
J Dairy Sci, December 1, 2003; 86(12): 3912 - 3919.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Dairy Science Association ®.